Daniel completed his Bachelor of Biomedical Science degree at Deakin University in 2017, before completing a Bachelor of Health and Medical Science (Hons) in 2018. His Honours project saw him working with gene knockout constructs in the malaria parasite, Plasmodium falciparum, to elucidate novel drug targets for future development.
In 2018, he began working at The University of Melbourne in the Bio21 Institute, undertaking various research and laboratory management responsibilities. His main project again focused on the Plasmodium parasite, testing the efficacy of various experimental drug analogues in vitro to find a novel antimalarial to replace current therapies in the face of rising antimalarial drug resistance.
Since beginning at QAEHS in 2022, Daniel is currently working on wastewater projects for ACIC and SEWAUS, and assisting in the detection of new psychoactive drugs (NPS) being used in the community.